Literature DB >> 25884456

Asian lupus in a multi-ethnic society: what can be learnt?

Alberta Hoi1.   

Abstract

Ethnic differences in systemic lupus erythematosus account for part of the variability in disease susceptibility and expression observed in patients. By studying these racial dissimilarities in a multi-ethnic society, it allows us greater understanding of disease epidemiology, natural history and pathogenesis affected by ethnicity. Disease outcomes and the effects on disability and quality of life have not been well studied in Asian lupus. Ethnic difference in patient perceptions of disease and treatment could also play a large role in adherence and ultimately disease outcome. Future studies that explore these areas may shed insight into better ways either to use existing treatment regimes or to measure efficacy of new therapies in lupus patients. Given the increased susceptibility and more severe disease manifestations, the Asia-Pacific region is well placed in studying disease outcomes and effects of novel therapies.
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical aspects; epidemiology; systemic lupus erythematous

Mesh:

Year:  2015        PMID: 25884456     DOI: 10.1111/1756-185X.12497

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  2 in total

1.  Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.

Authors:  Xuebing Feng; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Lingyun Sun
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

2.  Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study.

Authors:  Jacqueline K K Sit; Winnie K Y Chan
Journal:  Pediatr Rheumatol Online J       Date:  2018-09-10       Impact factor: 3.054

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.